Xinrong Ma

Summary

Affiliation: University of Maryland
Country: USA

Publications

  1. ncbi Promoter methylation regulates cyclooxygenase expression in breast cancer
    Xinrong Ma
    Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA
    Breast Cancer Res 6:R316-21. 2004
  2. ncbi Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer
    Tonya C Walser
    Department of Pathology, University of Maryland School of Medicine, 10 South Pine Street, Baltimore, MD 21201, USA
    Cancer Res 66:7701-7. 2006
  3. ncbi CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model
    Xinrong Ma
    University of Maryland Greenebaum Cancer Center, Department of Pathology, School of Medicine, 9th Floor, 655 West Baltimore Street, Baltimore, MD 21201, USA
    Mol Cancer Ther 8:490-8. 2009
  4. ncbi Immune-mediated modulation of breast cancer growth and metastasis by the chemokine Mig (CXCL9) in a murine model
    Tonya C Walser
    Department of Pathology, University of Maryland School of Medicine, 10 South Pine Street, Baltimore, MD 21201, USA
    J Immunother 30:490-8. 2007
  5. ncbi Antagonism of the prostaglandin E receptor EP4 inhibits metastasis and enhances NK function
    Namita Kundu
    Department of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    Breast Cancer Res Treat 117:235-42. 2009
  6. ncbi Prostaglandin E receptor EP4 antagonism inhibits breast cancer metastasis
    Xinrong Ma
    Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
    Cancer Res 66:2923-7. 2006
  7. ncbi Prostaglandin E receptor EP1 suppresses breast cancer metastasis and is linked to survival differences and cancer disparities
    Xinrong Ma
    University of Maryland, Greenebaum Cancer Center, Baltimore, MD 21201, USA
    Mol Cancer Res 8:1310-8. 2010
  8. ncbi Targeting prostaglandin E EP receptors to inhibit metastasis
    Amy M Fulton
    Department of Pathology and Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
    Cancer Res 66:9794-7. 2006
  9. ncbi Antimetastatic activity isolated from Colocasia esculenta (taro)
    Namita Kundu
    Marlene and Stewart Greenebaum Cancer Center, Baltimore, Maryland 21201, USA
    Anticancer Drugs 23:200-11. 2012
  10. ncbi Prostaglandin E(2) (PGE (2)) suppresses natural killer cell function primarily through the PGE(2) receptor EP4
    Dawn Holt
    Department of Pathology, School of Medicine, University of Maryland, Baltimore, USA
    Cancer Immunol Immunother 60:1577-86. 2011

Collaborators

Detail Information

Publications11

  1. ncbi Promoter methylation regulates cyclooxygenase expression in breast cancer
    Xinrong Ma
    Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA
    Breast Cancer Res 6:R316-21. 2004
    ..Aberrant CpG island methylation, and subsequent silencing of the COX-2 promoter, has been observed in human cancer cell lines and in some human tumors of the gastrointestinal tract...
  2. ncbi Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer
    Tonya C Walser
    Department of Pathology, University of Maryland School of Medicine, 10 South Pine Street, Baltimore, MD 21201, USA
    Cancer Res 66:7701-7. 2006
    ..These studies also indicate for the first time that a small molecular weight antagonist of CXCR3 has the potential to inhibit tumor metastasis...
  3. ncbi CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model
    Xinrong Ma
    University of Maryland Greenebaum Cancer Center, Department of Pathology, School of Medicine, 9th Floor, 655 West Baltimore Street, Baltimore, MD 21201, USA
    Mol Cancer Ther 8:490-8. 2009
    ..These studies support the continued examination of CXCR3 as a potential therapeutic target in patients with breast cancer...
  4. ncbi Immune-mediated modulation of breast cancer growth and metastasis by the chemokine Mig (CXCL9) in a murine model
    Tonya C Walser
    Department of Pathology, University of Maryland School of Medicine, 10 South Pine Street, Baltimore, MD 21201, USA
    J Immunother 30:490-8. 2007
    ..These studies also implicate host NK cells as an additional effector cell critical for Mig-mediated control of metastasis...
  5. ncbi Antagonism of the prostaglandin E receptor EP4 inhibits metastasis and enhances NK function
    Namita Kundu
    Department of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    Breast Cancer Res Treat 117:235-42. 2009
    ....
  6. ncbi Prostaglandin E receptor EP4 antagonism inhibits breast cancer metastasis
    Xinrong Ma
    Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
    Cancer Res 66:2923-7. 2006
    ..These studies support the hypothesis that EP receptor antagonists may be an alternative approach to the use of COX inhibitors to prevent tumor metastasis...
  7. ncbi Prostaglandin E receptor EP1 suppresses breast cancer metastasis and is linked to survival differences and cancer disparities
    Xinrong Ma
    University of Maryland, Greenebaum Cancer Center, Baltimore, MD 21201, USA
    Mol Cancer Res 8:1310-8. 2010
    ..04). These studies support the hypothesis that EP1 functions as a metastasis suppressor and that loss of nuclear EP1 is associated with poorer overall survival and may contribute to disparities in outcome in different populations...
  8. ncbi Targeting prostaglandin E EP receptors to inhibit metastasis
    Amy M Fulton
    Department of Pathology and Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
    Cancer Res 66:9794-7. 2006
    ..These initial results indicate that selective targeting of individual EP receptors should be investigated as an approach to exploit the high COX-2 activity in many epithelial malignancies...
  9. ncbi Antimetastatic activity isolated from Colocasia esculenta (taro)
    Namita Kundu
    Marlene and Stewart Greenebaum Cancer Center, Baltimore, Maryland 21201, USA
    Anticancer Drugs 23:200-11. 2012
    ..This is the first report describing compound(s) derived from taro that potently and specifically inhibits tumor metastasis...
  10. ncbi Prostaglandin E(2) (PGE (2)) suppresses natural killer cell function primarily through the PGE(2) receptor EP4
    Dawn Holt
    Department of Pathology, School of Medicine, University of Maryland, Baltimore, USA
    Cancer Immunol Immunother 60:1577-86. 2011
    ....
  11. ncbi Cyclooxygenase inhibitors modulate NK activities that control metastatic disease
    Namita Kundu
    Department of Pathology, University of Maryland, 10 S. Pine St, Baltimore, MD 21201, USA
    Cancer Immunol Immunother 54:981-7. 2005
    ..Taken together, these findings are consistent with a mechanism not previously described, whereby COX inhibitors may relieve MHC-mediated inhibition of NK cytotoxicity leading to recognition and lysis of metastatic tumor cells...